Literature DB >> 24381307

Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina.

Katherine J Wert1, Jessica M Skeie, Alexander G Bassuk, Alicia K Olivier, Stephen H Tsang, Vinit B Mahajan.   

Abstract

Exome sequencing indicated that the gene encoding the calpain-5 protease, CAPN5, is the likely cause of retinal degeneration and autoimmune uveitis in human patients with autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV, OMIM #193235). To explore the mechanism of ADNIV, a human CAPN5 disease allele was expressed in mouse retinas with a lentiviral vector created to express either the wild-type human (h) CAPN5 or the ADNIV mutant hCAPN5-R243L allele under a rhodopsin promoter with tandem green fluorescent protein (GFP) expression. Vectors were injected into the subretinal space of perinatal mice. Mouse phenotypes were analyzed using electroretinography, histology and inflammatory gene expression profiling. Mouse calpain-5 showed high homology to its human ortholog with >98% sequence identity that includes the ADNIV mutant residue. Calpain-5 protein was expressed in the inner and outer segments of the photoreceptors and in the outer plexiform layer. Expression of the hCAPN5-R243L allele caused loss of the electroretinogram b-wave, photoreceptor degeneration and induction of immune cell infiltration and inflammatory genes in the retina, recapitulating major features of the ADNIV phenotype. Intraocular neovascularization and fibrosis were not observed during the study period. Our study shows that expression of the hCAPN5-R243L disease allele elicits an ADNIV-like disease in mice. It further suggests that ADNIV is due to CAPN5 gain-of-function rather than haploinsufficiency, and retinal expression may be sufficient to generate an autoimmune response. Genetic models of ADNIV in the mouse can be used to explore protease mechanisms in retinal degeneration and inflammation as well as preclinical therapeutic testing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24381307      PMCID: PMC3990166          DOI: 10.1093/hmg/ddt661

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

Review 1.  Spare the rods, save the cones in aging and age-related maculopathy.

Authors:  C A Curcio; C Owsley; G R Jackson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

2.  Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa.

Authors:  Joaquin Tosi; Javier Sancho-Pelluz; Richard J Davis; Chun Wei Hsu; Kyle V Wolpert; Jesse D Sengillo; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  Exp Biol Med (Maywood)       Date:  2011-09-01

Review 3.  Proliferative vitreoretinopathy: risk factors and pathobiology.

Authors:  J Carlos Pastor; E Rodríguez de la Rúa; Francisco Martín
Journal:  Prog Retin Eye Res       Date:  2002-01       Impact factor: 21.198

4.  A novel calpain inhibitor for treatment of transient retinal ischemia in the rat.

Authors:  Joel David; Aleksandr Melamud; Leo Kesner; Steven Roth; Pearl S Rosenbaum; Frank C Barone; Sussana Popp; Getaw Worku Hassen; Alfred Stracher; Daniel M Rosenbaum
Journal:  Neuroreport       Date:  2011-09-14       Impact factor: 1.837

Review 5.  The calpain system and cancer.

Authors:  Sarah J Storr; Neil O Carragher; Margaret C Frame; Tim Parr; Stewart G Martin
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

6.  Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave.

Authors:  D C Hood; D G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-06       Impact factor: 4.799

7.  T-cell infiltration in autosomal dominant neovascular inflammatory vitreoretinopathy.

Authors:  Vinit B Mahajan; John G Vallone; Jonathan H Lin; Robert F Mullins; Audrey C Ko; James C Folk; Edwin M Stone
Journal:  Mol Vis       Date:  2010-06-08       Impact factor: 2.367

8.  Subretinal injection of gene therapy vectors and stem cells in the perinatal mouse eye.

Authors:  Katherine J Wert; Jessica M Skeie; Richard J Davis; Stephen H Tsang; Vinit B Mahajan
Journal:  J Vis Exp       Date:  2012-11-25       Impact factor: 1.355

9.  Role for the target enzyme in deactivation of photoreceptor G protein in vivo.

Authors:  S H Tsang; M E Burns; P D Calvert; P Gouras; D A Baylor; S P Goff; V Y Arshavsky
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

10.  Lymphocyte infiltration in CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathy.

Authors:  Vinit B Mahajan; Jonathan H Lin
Journal:  Clin Ophthalmol       Date:  2013-07-03
View more
  21 in total

1.  CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials.

Authors:  Katherine J Wert; Susanne F Koch; Gabriel Velez; Chun-Wei Hsu; MaryAnn Mahajan; Alexander G Bassuk; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mutat       Date:  2019-08-26       Impact factor: 4.878

2.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

3.  Small-angle X-ray scattering of calpain-5 reveals a highly open conformation among calpains.

Authors:  Lokesh Gakhar; Alexander G Bassuk; Gabriel Velez; Saif Khan; Jing Yang; Stephen H Tsang; Vinit B Mahajan
Journal:  J Struct Biol       Date:  2016-07-27       Impact factor: 2.867

Review 4.  Calpains as mechanistic drivers and therapeutic targets for ocular disease.

Authors:  Jennifer T Vu; Elena Wang; Jolan Wu; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Soo Hyeon Lee; Vinit B Mahajan
Journal:  Trends Mol Med       Date:  2022-05-29       Impact factor: 15.272

5.  CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.

Authors:  Wen-Hsuan Wu; Yi-Ting Tsai; Sally Justus; Ting-Ting Lee; Lijuan Zhang; Chyuan-Sheng Lin; Alexander G Bassuk; Vinit B Mahajan; Stephen H Tsang
Journal:  Mol Ther       Date:  2016-05-20       Impact factor: 11.454

6.  Two Novel CAPN5 Variants Associated with Mild and Severe Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy Phenotypes.

Authors:  Nadia M Randazzo; Morag E Shanks; Penny Clouston; Robert E MacLaren
Journal:  Ocul Immunol Inflamm       Date:  2017-10-17       Impact factor: 3.070

Review 7.  Effects of functionally diverse calpain system on immune cells.

Authors:  Yueqi Chen; Zhaoliang Su; Fang Liu
Journal:  Immunol Res       Date:  2021-01-23       Impact factor: 2.829

8.  Piccolo is essential for the maintenance of mouse retina but not cochlear hair cell function.

Authors:  Peipei Li; Zhuchun Lin; Yachun An; Jing Lin; Aizhen Zhang; Shuangyan Wang; Hailong Tu; Jie Ran; Jinpeng Wang; Yu Liang; Ziyi Liu; Chao Ye; Xiaolong Fu; Jiangang Gao
Journal:  Aging (Albany NY)       Date:  2021-04-21       Impact factor: 5.682

9.  Long-Term Outcomes and Risk Factors for Severe Vision Loss in Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV).

Authors:  Timothy M Boyce; S Scott Whitmore; Katayoun Varzavand; Stephen R Russell; Elliott H Sohn; James C Folk; Edwin M Stone; Ian C Han
Journal:  Am J Ophthalmol       Date:  2021-07-21       Impact factor: 5.488

10.  PROGRESSION OF SCOTOPIC SINGLE-FLASH ELECTRORETINOGRAPHY IN THE STAGES OF CAPN5 VITREORETINOPATHY.

Authors:  Peter H Tang; Tyson R Kinnick; James C Folk; MaryAnn Mahajan; Alexander G Bassuk; Stephen H Tsang; Vinit B Mahajan
Journal:  Retin Cases Brief Rep       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.